Amaryl (AM-a-ril, glimepiride), a new sulfonylurea for diabetes

Aventis is now marketing Amaryl (AM-a-ril, glimepiride), a new sulfonylurea for diabetes.

It will be used alone or combined with metformin or insulin.

Amaryl works as well as glyburide and gliclazide...and appears to have a lower risk of severe hypoglycemia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote